日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Stereotyped active sensing in fast-diving echolocating bats

快速潜水回声定位蝙蝠的刻板主动感知

Kloepper, Laura N; Tuninetti, Amaro; Bentley, Ian; Harding, Christian D; Brighton, Caroline H; Izadi, Mohammad Rasool; Stevenson, Robert L; Taylor, Graham K

Rational design of base, sugar and backbone modifications improves ADAR-mediated RNA editing

碱基、糖和骨架修饰的合理设计改善了ADAR介导的RNA编辑

Genliang Lu, Chikdu Shivalila, Prashant Monian, Hui Yu, Ian Harding, Stearne Briem, Michael Byrne, Alyse Faraone, Stephen Friend, Olivia Huth, Naoki Iwamoto, Tomomi Kawamoto, Jayakanthan Kumarasamy, Anthony Lamattina, Kenneth Longo, Leah McCarthy, Andrew McGlynn, Allison Molski, Qianli Pan, Tom Pu, 

Identification of C10 nitrogen-containing aporphines with dopamine D(1) versus D(5) receptor selectivity

鉴定具有多巴胺D(1)受体选择性和D(5)受体选择性的C10含氮阿朴啡

Karki, Anupam; Juarez, Reecan; Namballa, Hari K; Alberts, Ian; Harding, Wayne W

Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines

环C邻位卤代1-苯基苯并氮杂卓的合成及多巴胺受体药理学评价

Giri, Rajan; Namballa, Hari K; Sarker, Ananta; Alberts, Ian; Harding, Wayne W

Synthesis, pharmacological evaluations, and molecular docking studies on a new 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework: Rigidification of D(1) receptor selective 1-phenylbenzazepines and discovery of a new 5-HT(6) receptor scaffold

新型1,3,4,11b-四氢-1H-芴并[9,1-cd]氮杂卓骨架的合成、药理学评价和分子对接研究:D(1)受体选择性1-苯基苯并氮杂卓的刚性化及新型5-HT(6)受体骨架的发现

Giri, Rajan; Alberts, Ian; Harding, Wayne W

A case for stopping the early withdrawal of life sustaining therapies in patients with devastating brain injuries

一项关于停止对遭受严重脑损伤的患者过早撤除生命维持疗法的论证

Manara, Alex R; Thomas, Ian; Harding, Richard

Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29

利用新型单克隆抗体 692/29 对 Lewis(y) 和 Lewis(b) 进行治疗靶向治疗

Noble, Philip; Spendlove, Ian; Harding, Stephen; Parsons, Tina; Durrant, Lindy G